Creative One Wealth, LLC Invitae Corp Transaction History

Creative One Wealth, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.01 - $0.61 $180 - $10,980	18,000 Added 44.93%	58,064 $1,000
Q4 2023 Feb 09, 2024	SELL	$0.42 - $0.72 $210 - $360	-500 Reduced 1.23%	40,064 $25,000
Q3 2023 Oct 17, 2023	SELL	$0.6 - $1.53 $56,400 - $143,820	-94,000 Reduced 69.86%	40,564 $25,000
Q2 2023 Aug 16, 2023	BUY	$1.05 - $1.63 $39,673 - $61,587	37,784 Added 39.04%	134,564 $152,000
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $34,717 - $53,894	-33,064 Reduced 25.46%	96,780 $186,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $34,276 - $77,979	28,564 Added 28.2%	129,844 $175,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $4,275 - $9,025	2,500 Added 2.53%	101,280 $188,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $39,900 - $181,230	21,000 Added 27.0%	98,780 $243,000
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $10,341 - $43,743	4,855 Added 6.66%	77,780 $190,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $157,226 - $390,311	25,036 Added 52.28%	72,925 $581,000
Q4 2021 Feb 15, 2022	BUY	$14.7 - $28.67 $703,968 - $1.37 Million	47,889 New	47,889 $731,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Creative One Wealth, LLC with notifications on news.